

Instance: composition-en-7c3f725d5ce5b04f0bcec4815df3bcb5
InstanceOf: CompositionUvEpi
Title: "Composition for regkirona Package Leaflet"
Description:  "Composition for regkirona Package Leaflet"
Usage: #inline

* identifier.system = ""

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mock)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - regkirona"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  What is in this leaflet 
 
1. What Regkirona is and what it is used for  
2. What you need to know before you are given Regkirona  
3. How Regkirona is given to you  
4. Possible side effects  
5. How to store Regkirona 
6. Contents of the pack and other information 
         </div>"""   
          

* section[=].section[+]
  * title =  "1. What regkirona is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What regkirona is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>The active substance of Regkirona is regdanvimab. It is a monoclonal antibody used for the treatment 
of COVID-19, a disease caused by a virus called SARS-CoV-</p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take regkirona"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take regkirona"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Regkirona is given to adult patients with COVID-19 who do not require supplemental oxygen and 
who are at increased risk of progressing to severe COVID-1</p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take regkirona"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take regkirona"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>This medicine stops the virus from entering human cells by binding to the spike protein of 
SARS-CoV-2. When it attaches to the spike protein, the interaction between the virus and the cellular 
receptor is blocked and the ability of the virus to enter the body s cells is reduced. This can help your 
body to resist the virus infection, and may help to prevent the disease from getting worse. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not use Regkirona:</p>
<ul>
<li>if you are allergic to regdanvimab or any of the other ingredients of this medicine (listed in 
section 6).<br />
  Talk to your doctor or nurse as soon as possible, if this applies to you. </li>
</ul>
<p>Warnings and precautions  </p>
<p>Reactions after receiving the medicine<br />
This medicine can cause allergic reactions or other reactions after the medicine is given to you. See 
also section 4,  Possible side effects . Symptoms can include: 
* Fever 
* Difficulty breathing 
* Shortness of breath, rapid breathing or rapid heartbeat 
* Chills 
* Feeling tired 
* Irregular, rapid or slow heart rate 
* Chest discomfort or pain 
* Weakness 
* Confusion 
* Feeling sick (nausea) 
* Headache 
* Shortness of breath, wheezing 
* Low or high blood pressure 
* Swelling of the face, lips, or throat (angioedema) 
* Rash including nettle rash 
* Itching 
* Muscle aches 
* Feeling faint 
* Dizziness 
* Sweating </p>
<p>Seek urgent medical advice if you get any of these symptoms. </p>
<p>Children and adolescents 
This medicine is not to be given to children and adolescents under 18 years of age because there are no 
data to show that this medicine is safe and works in this age group. </p>
<p>Other medicines and Regkirona 
Tell your doctor or nurse about any other medicines you are taking, or have recently taken. </p>
<p>It is not yet known if this medicine affects other medicines, or if it is affected by them. Your 
healthcare team will monitor you for signs of medicines affecting each other. </p>
<p>Pregnancy and breast-feeding 
If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor 
for advice before receiving Regkirona. Your doctor will advise you whether the benefits of treatment 
with Regkirona are greater than any likely risks for you and your baby.  </p>
<p>It is not known whether the ingredients of Regkirona can pass into breast milk. If you are 
breast-feeding, you must check with your doctor before you receive Regkirona.  </p>
<p>Driving and using machines 
Regkirona is not expected to have any effect on your ability to drive or use tools or machines.  </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store regkirona"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store regkirona"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>This medicine will be given to you by a nurse or doctor, as a drip into a vein (an intravenous infusion) 
lasting 60 minutes.  </p>
<p>The recommended dose is a single dose of 40 mg/kg. This medicine should be given within 7 days of 
symptom onset. </p>
<p>This medicine can cause infusion reactions after the medicine is given to you. You will be closely 
monitored during your treatment and for at least 1 hour after infusion is complete. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>Tell your doctor or nurse if you notice any of the following side effects: </p>
<ul>
<li>Uncommon: may affect up to 1 in 100 people </li>
<li>Allergic reactions due to an infusion (e.g. fever, difficulty breathing, irregular, rapid or 
slow heart rate, high blood pressure, rash including nettle rash, itching, feeling faint) </li>
</ul>
<p>In general, these types of reactions occur within minutes to several hours following completion of the 
infusion. </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not 
listed in this leaflet. You can also report side effects directly via the national reporting system listed in 
Appendix V. By reporting side effects, you can help provide more information on the safety of this 
medicine. </p>         </div>"""      

